Irene Ni

1.1k total citations
15 papers, 743 citations indexed

About

Irene Ni is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Irene Ni has authored 15 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Irene Ni's work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Irene Ni is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Irene Ni collaborates with scholars based in United States, Netherlands and United Kingdom. Irene Ni's co-authors include Arvind Rajpal, Wenwu Zhai, Purnima Sundar, Jacob Glanville, Jaume Pons, Dilduz Telman, Li Mei, David Cox, Gabriella Huerta and Jan Berka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Irene Ni

15 papers receiving 714 citations

Peers

Countries citing papers authored by Irene Ni

Since Specialization

Citations

This map shows the geographic impact of Irene Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Ni more than expected).

Fields of papers citing papers by Irene Ni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Ni. The network helps show where Irene Ni may publish in the future.

Co-authorship network of co-authors of Irene Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Ni. A scholar is included among the top collaborators of Irene Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Ni. Irene Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	1083 AB821 is a CD8+ T cell selective IL-21 with enhanced bioavailability that mediates potent anti-tumor activity, cytotoxicity, and expansion of memory CD8+ T cells 2022 ·Regular and Young Investigator Award Abstracts ·Renee L. Greer, Henry T. Nguyen, (unknown), Ruth Y. Lan, Wei Wei Prior, Hussein Sultan, (unknown), Irene Ni, (unknown), Kelly D. Moynihan, Ton N. Schumacher, Robert D. Schreiber, Andy Wai Kan Yeung, Ivana M. Djuretic	2
2	1092 The CD8+ T cell selectivity of AB248 is essential for optimal anti-tumor activity and safety in nonclinical models 2022 ·Regular and Young Investigator Award Abstracts ·Kelly D. Moynihan, Danielle C. Pappas, Hussein Sultan, (unknown), Manu Kumar, Ruth Y. Lan, Irene Ni, (unknown), Michael T. Chin, Ton N. Schumacher, Andy Wai Kan Yeung, Robert D. Schreiber, Ivana M. Djuretic	4
3	One size does not fit all: navigating the multi-dimensional space to optimize T-cell engaging protein therapeutics 2021 ·mAbs ·Wei Chen, Fan Yang, (unknown), Jatin Narula, Edward Pascua, Irene Ni, Sheng Ding, Xiaodi Deng, Matthew Ling-Hon Chu, Amber Pham, Xiaoyue Jiang, Kevin C. Lindquist, Patrick J. Doonan, (unknown), Yik A. Yeung, Javier Chaparro‐Riggers	36
4	717 Selective activation of CD8+ T cells by a CD8-targeted IL-2 results in enhanced anti-tumor efficacy and safety 2021 ·SHILAP Revista de lepidopterología ·Kelly D. Moynihan, Danielle C. Pappas, (unknown), Wei Chen, Irene Ni, Paul Bessette, (unknown), Ton N. Schumacher, (unknown), Ivana M. Djuretic	5
5	An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity 2020 ·Molecular Therapy ·Yik A. Yeung, Veena Krishnamoorthy, (unknown), Cesar Sommer, Kris Poulsen, Irene Ni, Amber Pham, Wei Chen, Sindy Liao-Chan, Kevin C. Lindquist, Sherman M. Chin, (unknown), Wenyue Hu, Barbra J. Sasu, Javier Chaparro‐Riggers, Ivana M. Djuretic	26
6	Antibodies Targeting Closely Adjacent or Minimally Overlapping Epitopes Can Displace One Another 2017 ·PLoS ONE ·Yasmina Abdiche, (unknown), Irene Ni, Donna M. Stone, Adam Miles, (unknown), Andrea Rossi, Pavel Strop	30
7	Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire 2016 ·Nature Communications ·Yik A. Yeung, Davide Foletti, Xiaodi Deng, Yasmina Abdiche, Pavel Strop, Jacob Glanville, Steven J. Pitts, Kevin C. Lindquist, Purnima Sundar, Marina Sirota, Adela Hasa-Moreno, Amber Pham, Jody Melton Witt, Irene Ni, Jaume Pons, David L. Shelton, Arvind Rajpal, Javier Chaparro‐Riggers	30
8	Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis 2015 ·Journal of Neuroimmune Pharmacology ·(unknown), Li‐Fen Lee, Nikki van Driel, Jon D. Laman, Irene Ni, Wenwu Zhai, (unknown), John Lin, Jan Bauer, Bert A. ‘t Hart, Yolanda S. Kap	18
9	Anti–IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function 2012 ·Proceedings of the National Academy of Sciences ·Li‐Fen Lee, Kathryn Logronio, Guang Huan Tu, Wenwu Zhai, Irene Ni, Mei Li, Jeanette Dilley, Jessica Yu, Arvind Rajpal, Colleen Brown, (unknown), Sherman M. Chin, Bora Han, (unknown), John Lin	110
10	Synthetic Antibodies Designed on Natural Sequence Landscapes 2011 ·Journal of Molecular Biology ·Wenwu Zhai, Jacob Glanville, Markus Fuhrmann, Li Mei, Irene Ni, Purnima Sundar, Thomas Van Blarcom, Yasmina Abdiche, Kevin C. Lindquist, Ralf Strohner, Dilduz Telman, (unknown), William J.J. Finlay, Jan Brülle, David R. Cox, Jaume Pons, Arvind Rajpal	70
11	Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire 2009 ·Proceedings of the National Academy of Sciences ·Jacob Glanville, Wenwu Zhai, Jan Berka, Dilduz Telman, Gabriella Huerta, (unknown), Irene Ni, Li Mei, Purnima Sundar, (unknown), David Cox, Arvind Rajpal, Jaume Pons	339
12	Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activityin vitroand in human tumor xenografts 2008 ·Molecular Cancer Therapeutics ·Jay Sarup, Jin Pei, (unknown), Xiaomei Bai, Malgorzata Beryt, Cathleen Brdlik, Jeffrey N. Higaki, Brett Jorgensen, Francis W. Lau, Peter F. Lindley, Jim Liu, Irene Ni, (unknown), Rajendra Kumari, Susan A. Watson, Juan Zhang, H. Michael Shepard	28
13	Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis 2008 ·Arthritis Research & Therapy ·Jin Pei, Juan Zhang, Percy F. Sumariwalla, Irene Ni, Brett Jorgensen, (unknown), (unknown), Marc Feldmann, H. Michael Shepard, Ewa Paleolog	33
14	Antagonism of the human epidermal growth factor receptor family controls disease severity in murine collagen‐induced arthritis 2008 ·Arthritis & Rheumatism ·Percy F. Sumariwalla, Jin Pei, Juan Zhang, Irene Ni, (unknown), H. Michael Shepard, Ewa Paleolog, Marc Feldmann	11
15	Agarose gel size fractionation of RNA for the cloning of full-length cDNAs 2003 ·Analytical Biochemistry ·Alan A. Jackson, (unknown), Irene Ni, Glenn K. Fu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact